Alexandre Chebaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexandre Chebaro has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Edouard Girard
Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France
2 shared publications - François Faitot
Hepatobiliopancreatic Surgery and Transplantation Department, Hopital de Hautepierre, Hopitaux Universitaires de Strasbourg, France; Laboratoire ICube, UMR7357, University of Strasbourg, France
2 shared publications Karim Boudjema
Department of Hepatobiliary and Digestive Surgery, University of Rennes, CHU Rennes, Rennes, France
2 shared publications- Karim Boudjema
Department of Hepatobiliary and Digestive Surgery, Pontchaillou University Hospital, Rennes, France
2 shared publications Laurent Sulpice
Department of Hepatobiliary and Digestive Surgery, CHU Rennes, Pontchaillou Hospital, University of Rennes 1, Rennes, France
2 shared publications- Michel Rayar
CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, Rennes, France
2 shared publications
Latest Publications
- Open Access
- 18 March 2026
- Published by Elsevier in JHEP Reports
- Vol. 8 (7) , 101830
Liver transplantation in unresectable intrahepatic cholangiocarcinoma following neoadjuvant chemotherapy and SIRT
- 18 March 2026
- Published by Elsevier in JHEP Reports
- Vol. 8 (7) , 101830
Open AccessLiver transplantation in unresectable intrahepatic cholangiocarcinoma following neoadjuvant chemotherapy and SIRT
- 18 October 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (3) , 607-620
A French multicenter randomized controlled trial of hypothermic oxygenated perfusion in extended criteria donor liver transplantation
- 18 October 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (3) , 607-620
A French multicenter randomized controlled trial of hypothermic oxygenated perfusion in extended criteria donor liver transplantation
- Open Access
- 4 February 2022
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 27, e935892-1-e935892-14
The Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation
Few series of cavoportal (CPA) or renoportal (RPA) anastomosis have been published and their survival rates have never been compared. The objective of this study was to evaluate perioperative and long-term outcomes of CPA and RPA in a nationwide multicentric series and to compare hemitranspositions (HT) to paired orthotopic liver transplantations (OLT). HT performed in France up to April 2019 were analyzed. Endpoints were the incidence of severe (Clavien-Dindo>IIIa) 90-day perioperative complications and long-term patient and graft survival. Sixty-four HT (13 CPA, 51 RPA) were performed in 59 patients. The rates of perioperative CD>IIIa complications were 64% and 49% in patients with CPA and RPA, respectively (P=0.59), and the rates of portal thrombosis and ascites were 38.5% and 9.8% (p=0.023) and 53.8% and 21.6% (p=0.049) in patients with CPA and RPA, respectively. The patient and graft perioperative survival rates were 54.4% and 83.3% (HR=3.2; CI 95 [1.1–9.9]; p=0.039) and 54.4% and 77.1% (HR=2.2; CI 95 [0.77–6.4]; P=0.14) in the CPA and RPA groups, respectively. Five-year patient survival was 36.4% and 61.8% in the CPA and RPA groups, respectively (HR=2.5; CI 95 [1–6.1]; P=0.039). Compared with OLT grafts, long-term HT graft survival rates were not different (HR=1.7; CI 95 [0.96–3.1]; P=0.066), while patient survival rates were lower in the HT group (HR=4.6; CI 95 [2–11]; P<0.001). Compared to OLT, HT significantly reduces patient survival. Given the poor survival results of CPA, the indication deserves to be limited in the context of organ shortage and RPA should be preferred when HT is needed.
- 4 February 2022
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 27, e935892-1-e935892-14
Open AccessThe Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation
Few series of cavoportal (CPA) or renoportal (RPA) anastomosis have been published and their survival rates have never been compared. The objective of this study was to evaluate perioperative and long-term outcomes of CPA and RPA in a nationwide multicentric series and to compare hemitranspositions (HT) to paired orthotopic liver transplantations (OLT). HT performed in France up to April 2019 were analyzed. Endpoints were the incidence of severe (Clavien-Dindo>IIIa) 90-day perioperative complications and long-term patient and graft survival. Sixty-four HT (13 CPA, 51 RPA) were performed in 59 patients. The rates of perioperative CD>IIIa complications were 64% and 49% in patients with CPA and RPA, respectively (P=0.59), and the rates of portal thrombosis and ascites were 38.5% and 9.8% (p=0.023) and 53.8% and 21.6% (p=0.049) in patients with CPA and RPA, respectively. The patient and graft perioperative survival rates were 54.4% and 83.3% (HR=3.2; CI 95 [1.1–9.9]; p=0.039) and 54.4% and 77.1% (HR=2.2; CI 95 [0.77–6.4]; P=0.14) in the CPA and RPA groups, respectively. Five-year patient survival was 36.4% and 61.8% in the CPA and RPA groups, respectively (HR=2.5; CI 95 [1–6.1]; P=0.039). Compared with OLT grafts, long-term HT graft survival rates were not different (HR=1.7; CI 95 [0.96–3.1]; P=0.066), while patient survival rates were lower in the HT group (HR=4.6; CI 95 [2–11]; P<0.001). Compared to OLT, HT significantly reduces patient survival. Given the poor survival results of CPA, the indication deserves to be limited in the context of organ shortage and RPA should be preferred when HT is needed.
- 1 December 2018
- Published by Elsevier in Clinical Therapeutics
- Vol. 40 (12) , 2088-2098
Tacrolimus Concentrations Measured in Excreted Bile in Liver Transplant Recipients: The STABILE Study
- 1 December 2018
- Published by Elsevier in Clinical Therapeutics
- Vol. 40 (12) , 2088-2098
Tacrolimus Concentrations Measured in Excreted Bile in Liver Transplant Recipients: The STABILE Study